Similar articles

• Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas.

  Cuenca X, Hennequin C, Hindié E, Rivera S, Vercellino L, Baruch-Hennequin V, Gornet JM, Cattan P, Chirica M, Quéro L. Cuenca X, et al. Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):477-85. doi: 10.1007/s00259-012-2325-3. Epub 2013 Feb 1. Eur J Nucl Med Mol Imaging. 2013. PMID: 23371374
• Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer.

  Stiekema J, Vermeulen D, Vegt E, Voncken FE, Aleman BM, Sanders J, Boot H, van Sandick JW. Stiekema J, et al. Clin Nucl Med. 2014 Oct;39(10):862-7. doi: 10.1097/RLU.0000000000000517. Clin Nucl Med. 2014. PMID: 25140549
• The value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancer.

  Rankin S. Rankin S. Cancer Imaging. 2011 Oct 3;11 Spec No A(1A):S156-60. doi: 10.1102/1470-7330.2011.9040. Cancer Imaging. 2011. PMID: 22186083 Free PMC article. Review.
• High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer.

  Calais J, Dubray B, Nkhali L, Thureau S, Lemarignier C, Modzelewski R, Gardin I, Di Fiore F, Michel P, Vera P. Calais J, et al. Eur J Nucl Med Mol Imaging. 2015 May;42(6):858-67. doi: 10.1007/s00259-015-3004-y. Epub 2015 Feb 14. Eur J Nucl Med Mol Imaging. 2015. PMID: 25680400
• The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.

  Chowdhury FU, Bradley KM, Gleeson FV. Chowdhury FU, et al. Clin Radiol. 2008 Dec;63(12):1297-309. doi: 10.1016/j.crad.2008.05.010. Epub 2008 Aug 21. Clin Radiol. 2008. PMID: 18996259 Review.